SANGAMO THERAPEUTICS INC (SGMOQ) Net Income by Year
SANGAMO THERAPEUTICS INC reported a net loss of $122.9M in fiscal year 2025. This represents a decrease of 25.5% from the prior fiscal year. Over the trailing 12 months, Q2 FY2025 through Q1 FY2026, the same line adds up to a $123.3M net loss. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters SANGAMO THERAPEUTICS INC has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
SGMOQ Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | TTM | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$123.3M | -$122.9M-25.5% | -$97.9M+62.0% | -$257.8M-34.1% | -$192.3M-7.8% | -$178.3M-47.3% | -$121.0M-27.1% | -$95.2M-39.3% | -$68.3M-25.2% | -$54.6M+23.8% | -$71.7M-76.1% | -$40.7M-54.1% | -$26.4M+0.8% | -$26.6M-19.6% | -$22.3M+37.7% | -$35.8M |
TTM is the trailing twelve months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings.
SGMOQ Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More SANGAMO THERAPEUTICS INC financials
Frequently Asked Questions
What was SANGAMO THERAPEUTICS INC's net income in fiscal year 2025?
SANGAMO THERAPEUTICS INC reported a net loss of $122.9M in fiscal year 2025.
How fast is SANGAMO THERAPEUTICS INC's net income growing?
SANGAMO THERAPEUTICS INC (SGMOQ) net income fell by 25.5% year over year, from -$97.9M to -$122.9M in fiscal year 2025.
What is SANGAMO THERAPEUTICS INC's net income over the last twelve months?
SANGAMO THERAPEUTICS INC (SGMOQ) reported a $123.3M net loss over the trailing 12 months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings.
How has SANGAMO THERAPEUTICS INC's net income changed over the years?
Across the 15 fiscal years this page covers, SANGAMO THERAPEUTICS INC (SGMOQ) net income went from -$35.8M in fiscal year 2011 to -$122.9M in fiscal year 2025.
What was SANGAMO THERAPEUTICS INC's net income in the most recent quarter?
SANGAMO THERAPEUTICS INC (SGMOQ) reported -$31.0M in net income in Q1 2026. This represents a decrease of 1.3% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what SANGAMO THERAPEUTICS INC (SGMOQ) reported on that line in every period on record.